非ST段抬高急性冠状动脉综合征的药物治疗进展

Progress of Drug Treatment in Acute Coronary Syndrome without ST Segment Elevation

非ST段抬高急性冠状动脉综合征包括不稳定型心绞痛和非ST段抬高心肌梗死,是一种严重的、具有潜在危险性的疾病,治疗的目的是即刻缓解缺血症状和避免不良后果。近年来,非ST段抬高冠状动脉综合征的药物治疗已不局限于传统方面,新药(例如应用于抗凝治疗的磺达肝癸钠)与新技术的应用在挽救患者生命的同时也极大地提高了患者的生活质量。

Acute coronary syndrome without ST segment elevation includes unstable angina and non-ST segment elevation myocardial infarction.It is a severe and latent fata disease.The aim of treatment is to relieve ischemic symptoms immediately and to avoid harmful consequences.Recently,there are some new researches on the pathology and physiology of acute coronary syndrome without ST segment elevation.For medical treatment,new drugs and new techniques are applied and improve patient′s quality of life.For example,the fondaparinux is a new type of drug,whose curative effect is better than others.